Crossmark

Recurrence after preoperative chemotherapy and surgery for gastric adenocarcinoma: a multicenter study

Crossref DOI link: https://doi.org/10.1007/s10120-019-00956-6

Published Online: 2019-04-04

Published Print: 2019-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mokadem, I.

Dijksterhuis, W. P. M. https://orcid.org/0000-0002-3516-6743
van Putten, M.

Heuthorst, L.

de Vos-Geelen, J. M.

Haj Mohammad, N.

Nieuwenhuijzen, G. A. P.

van Laarhoven, H. W. M.

Verhoeven, R. H. A.
License Information

Text and Data Mining valid from 2019-04-04
More Information

Article History

Received: 25 September 2018

Accepted: 23 March 2019

First Online: 4 April 2019

Compliance with ethical standards

:

: H.W.M. van Laarhoven has served as a consultant for Celgene, Lilly, and Nordic, and has received unrestricted research funding from Bayer, BMS, Celgene, Liliy, Merck Serono, MSD, Nordic, Philips, and Roche. All other authors declare that they have no financial or non-financial conflict of interest.